Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000640874 | SCV000762478 | likely benign | X-linked lymphoproliferative disease due to XIAP deficiency | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004025613 | SCV004980411 | uncertain significance | Inborn genetic diseases | 2022-09-06 | criteria provided, single submitter | clinical testing | The c.688G>A (p.V230I) alteration is located in exon 2 (coding exon 1) of the XIAP gene. This alteration results from a G to A substitution at nucleotide position 688, causing the valine (V) at amino acid position 230 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |